BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32694282)

  • 1. Inter- and intraobserver agreement in standard and ultra-fast single-photon emission computed tomography/computed tomography for the assessment of bone metastases.
    Zacho HD; Aleksyniene R; Ejlersen JA; Fledelius J; Petersen LJ
    Nucl Med Commun; 2020 Oct; 41(10):1005-1009. PubMed ID: 32694282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT.
    Zacho HD; Manresa JAB; Aleksyniene R; Ejlersen JA; Fledelius J; Bertelsen H; Petersen LJ
    EJNMMI Res; 2017 Dec; 7(1):1. PubMed ID: 28058659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.
    Bashank N; Hussein A; Mekawy M; Askar H
    Nucl Med Commun; 2023 Jul; 44(7):604-612. PubMed ID: 37114413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
    Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body bone SPECT in breast cancer patients: the future bone scan protocol?
    Abikhzer G; Gourevich K; Kagna O; Israel O; Frenkel A; Keidar Z
    Nucl Med Commun; 2016 Mar; 37(3):247-53. PubMed ID: 26528786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
    Arvola S; Seppänen M; Malaspina S; Mätzke S; Raiko J; Timonen KL; Ettala O; Jambor I; Anttinen M; Kuisma A; Löyttyniemi E; Boström PJ; Sohlberg A; Noponen T
    Nucl Med Commun; 2022 May; 43(5):510-517. PubMed ID: 35081092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
    Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
    Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of Prostate-Specific Membrane Antigen-Positive Lesions.
    Schmidkonz C; Atzinger A; Goetz TI; Beck M; Ritt P; Prante O; Kuwert T; Bäuerle T; Cordes M
    Clin Nucl Med; 2020 Feb; 45(2):105-112. PubMed ID: 31876822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate.
    Helyar V; Mohan HK; Barwick T; Livieratos L; Gnanasegaran G; Clarke SE; Fogelman I
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):706-13. PubMed ID: 20016889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
    de Leiris N; Leenhardt J; Boussat B; Montemagno C; Seiller A; Phan Sy O; Roux J; Laramas M; Verry C; Iriart C; Fiard G; Long JA; Descotes JL; Vuillez JP; Riou L; Djaileb L
    Cancer Imaging; 2020 Aug; 20(1):58. PubMed ID: 32787923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D SPECT/CT fusion using image data projection of bone SPECT onto 3D volume-rendered CT images: feasibility and clinical impact in the diagnosis of bone metastasis.
    Ogata Y; Nakahara T; Ode K; Matsusaka Y; Katagiri M; Iwabuchi Y; Itoh K; Ichimura A; Jinzaki M
    Ann Nucl Med; 2017 May; 31(4):304-314. PubMed ID: 28243844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indeterminate lesions on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT-CT?
    Sharma P; Kumar R; Singh H; Bal C; Julka PK; Thulkar S; Malhotra A
    Skeletal Radiol; 2012 Jul; 41(7):843-50. PubMed ID: 22002100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.
    Tuncel M; Lay Ergun E; Caglar Tuncali M
    J BUON; 2016; 21(5):1296-1306. PubMed ID: 27837636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.
    Stecco A; Lombardi M; Leva L; Brambilla M; Negru E; Delli Passeri S; Carriero A
    Radiol Med; 2013 Apr; 118(3):465-75. PubMed ID: 22872462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
    Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H
    Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
    Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
    Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.